4
Changes in Ownership
KALA BIO, Inc. Filed Acc 0001179110-20-000157
Options or other derivatives
- Chief Scientific Officer acquired 120,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Chen Hongming · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-01-02 | Grant or award : show line 1 in the form Stock Option (right to buy) | +120,000 | $3.84 | 2030-01-01 | 120,000 | 120,000 | D |
Loading xslF345X03/edgar.xml…